Stay updated with breaking news from Open Orphan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Open Orphan PLC (AIM:ORPH, OTC:OPORF)'s Dr. Andrew Catchpole joins Proactive London to talk through the key insights found from the SARS-CoV-2...
LONDON (Reuters) -The world's first human challenge trial in which volunteers were deliberately exposed to COVID-19 to advance research into the disea...
No serious adverse events occurred, and the human challenge study model was shown to be safe
The world's first human challenge trial in which volunteers were deliberately exposed to Covid-19 to advance research into the disease was found to be safe in healthy young adults, one of the companies running the study said on Wednesday. The data supports the safety of this model which could theoretically provide a "plug and play" platform for testing therapies and vaccines
Findings from the UK's world-leading human challenge study provide new insights into mild infections with SARS-CoV-2 in healthy young adults.